REFERENCES
  1. Watkins T, Surowiecka MK, McCullough J. Transfusion indications for patients with cancer. Cancer Control. 2015;22:38-46.
  2. Nottage K, Gurney JG, Smeltzer M, Castellanos M, Hudson MM, Hankins JS. Trends in transfusion burden among long-term survivors of childhood hematological malignancies. Leuk lymphoma. 2013;54:1719-1723.
  3. Telfer PT, Prestcott E, Holden S, Walker M, Hoffbrand AV, Wonke B. Hepatic iron concentration combined with long-term monitoring of serum ferritin to predict complications of iron overload in thalassaemia major. Br J Haematol. 2000;110:971-977.
  4. Wood JC. Magnetic resonance imaging measurement of iron overload. Curr Opi Hematol. 2007;14:183-190.
  5. Kirk P, He T, Anderson LJ, et al. International reproducibility of single breathhold T2* MR for cardiac and liver iron assessment among five thalassemia centers. J Magn Reson Imaging. 2010;32:315-319.
  6. Hankins JS, McCarville MB, Loeffler RB, et al. R2* magnetic resonance imaging of the liver in patients with iron overload. Blood. 2009;113:4853-4855.
  7. Carpenter JP, He T, Kirk P, et al. On T2* magnetic resonance and cardiac iron. Circulation. 2011;123:1519-1528.
  8. Vora A, Goulden N, Wade R, et al. Treatment reduction for children and young adults with low-risk acute lymphoblastic leukaemia defined by minimal residual disease (UKALL 2003): a randomised controlled trial. Lancet Oncol. 2013;14:199-209.
  9. Burnett AK, Russell NH, Hills RK, et al. Optimization of chemotherapy for younger patients with acute myeloid leukemia: results of the medical research council AML15 trial. J Clin Oncol. 2013;31:3360-3368.
  10. Shenoy N, Vallumsetla N, Rachmilewitz E, Verma A, Ginzburg Y. Impact of iron overload and potential benefit from iron chelation in low-risk myelodysplastic syndrome. Blood. 2014;124:873-881.
  11. Papanikolaou G, Pantopoulos K. Iron metabolism and toxicity. Toxicol Appl Pharmacol. 2005;202:199-211.
  12. Cappellini MD, Cohen A, Porter J, Taher A, Viprakasit V. Guidelines for the Management of Transfusion Dependent Thalassaemia (TDT). 3rd edition. Nicosia, Cyprus. 2014.
  13. Weinberg ED. The hazards of iron loading. Met Integr Biometal Sci. 2010;2:732-740.
  14. Hartmann J, Braulke F, Sinzig U, et al. Iron overload impairs proliferation of erythroid progenitors cells (BFU-E) from patients with myelodysplastic syndromes. Leuk Res. 2013;37(3):327–332.
  15. Weinberg ED. Iron withholding: a defense against viral infections. Biometals Int J Role Met Ions Biol Biochem Med. 1996;9(4):393–399.
  16. Weinberg ED. Iron in neoplastic disease. Nutr Cancer. 1983;4:223–233
  17. Koreth J, Antin JH. Iron overload in hematologic malignancies and outcome of allogeneic hematopoietic stem cell transplantation. Haematologica. 2010;95:364-366.
  18. Barton JC, Bertoli LF. Transfusion iron overload in adults with acute leukemia: manifestations and therapy. Am J Med Sci. 2000;319:73-78.
  19. Halonen P, Mattila J, Suominen P, Ruuska T, Salo MK, Mäkipernaa A. Iron overload in children who are treated for acute lymphoblastic leukemia estimated by liver siderosis and serum iron parameters. Pediatrics. 2003;111:91-96.
  20. Olcay L, Hazirolan T, Yildirmak Y, et al. Biochemical, radiologic, ultrastructural, and genetic evaluation of iron overload in acute leukemia and iron-chelation therapy. J Pediatr Hematol Oncol. 2014;36:281-292.
  21. Nair M, Kuttath V, Nair AR, et al. Iron Overload in Children with Leukemia Receiving Multiple Blood Transfusions. Indian Pediatr. 2018;55:962-965.
  22. Ruccione KS, Wood JC, Sposto R, Malvar J, Chen C, Freyer DR. Characterization of transfusion-derived iron deposition in childhood cancer survivors. Cancer Epidemiol Biomark. 2014;23:1913–1919.
  23. Schempp A, Lee J, Kearney S, Mulrooney DA, Smith AR. Iron Overload in Survivors of Childhood Cancer. J Pediatr Hematol Oncol. 2016;38:27–31.
  24. Au WY, Lam WM, Chu WC, et al. A magnetic resonance imaging study of iron overload in hemopoietic stem cell transplant recipients with increased ferritin levels. Transplant Proc. 2007;39:3369-3374.
  25. Vag T, Kentouche K, Krumbein I, et al. Noninvasive measurement of liver iron concentration at MRI in children with acute leukemia: initial results. Pediatr Radiol. 2011;41:980-984.
  26. Unal S, Cetin M, Hazirolan T, et al. Number of erythrocyte transfusions is more predictive than serum ferritin in estimation of cardiac iron loading in pediatric patients with acute lymphoblastic leukemia. Leuk Res. 2014;38:882-885.
  27. Chirico V, Rigoli L, Lacquaniti A, et al. Endocrinopathies, metabolic disorders, and iron overload in major and intermedia thalassemia: serum ferritin as diagnostic and predictive marker associated with liver and cardiac T2* MRI assessment. Eur J Haematol. 2015;94:404-412.
  28. Armand P, Kim HT, Rhodes J, et al. Iron overload in patients with acute leukemia or MDS undergoing myeloablative stem cell transplantation. Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant. 2011;17:852-860.
  29. de Ville de Goyet M, Moniotte S, Robert A, et al. Iron overload in children undergoing cancer treatments. Pediatr Blood Cancer. 2013;60:1982-1987.
  30. Rascon J, Rageliene L, Stankeviciene S, et al. An assessment of iron overload in children treated for cancer and nonmalignant hematologic disorders. Eur J Pediatr. 2014;173:1137-1146.
  31. Gurram MK, Newman W, Kobrinsky N. Prevalence of iron overload in pediatric oncology patients after blood transfusion. Clin Adv Hematol Oncol HO. 2012;10:363-365.
  32. Acar S, Gözmen S, Bayraktaroğlu S, et al. Evaluation of Liver Iron Content by Magnetic Resonance Imaging in Children with Acute Lymphoblastic Leukemia after Cessation of Treatment. Turk J Haematol. 2020;37:263-270.
  33. Sait S, Zaghloul N, Patel A, et al. Transfusion related iron overload in pediatric oncology patients treated at a tertiary care centre and treatment with chelation therapy. Pediatr Blood Cancer. 2014;61:2319-2320.
  34. Sirvent A, Auquier P, Oudin C, et al. Prevalence and risk factors of iron overload after hematopoietic stem cell transplantation for childhood acute leukemia: a LEA study. Bone Marrow Transplant. 2017;52:80-87.
  35. Ktena YP, Athanasiadou A, Lambrou G, Adamaki M, Moschovi M. Iron chelation with deferasirox for the treatment of secondary hemosiderosis in pediatric oncology patients: a single-center experience. J Pediatr Hematol Oncol. 2013;35:447-450.
  36. Armstrong GT, Plana JC, Zhang N, et al. Screening adult survivors of childhood cancer for cardiomyopathy: comparison of echocardiography and cardiac magnetic resonance imaging. J Clin Oncol Off J Am Soc Clin Oncol. 2012;30:2876-2884.
  37. Ylänen K, Poutanen T, Savikurki-Heikkilä P, Rinta-Kiikka I, Eerola A, Vettenranta K. Cardiac magnetic resonance imaging in the evaluation of the late effects of anthracyclines among long-term survivors of childhood cancer. J Am Coll Cardiol. 2013;61:1539-1547.
  38. Cheung Y-F, Lam WW-M, Ip JJ-K, et al. Myocardial iron load and fibrosis in long term survivors of childhood leukemia. Pediatr Blood Cancer. 2015;62:698-703.
  39. Lutz K, von Komorowski G, Dürken M, Engelhardt R, Dinter DJ. Myocardial iron overload in transfusion-dependent pediatric patients with acute leukemia. Pediatr Blood Cancer. 2008;51:691-693.